210 related articles for article (PubMed ID: 8980108)
1. Structural classification of CDR-H3 in antibodies.
Shirai H; Kidera A; Nakamura H
FEBS Lett; 1996 Dec; 399(1-2):1-8. PubMed ID: 8980108
[TBL] [Abstract][Full Text] [Related]
2. H3-rules: identification of CDR-H3 structures in antibodies.
Shirai H; Kidera A; Nakamura H
FEBS Lett; 1999 Jul; 455(1-2):188-97. PubMed ID: 10428499
[TBL] [Abstract][Full Text] [Related]
3. [Molecular modeling of immunological proteins by bioinformatics].
Nakamura H
Nihon Rinsho; 1998 Mar; 56(3):795-802. PubMed ID: 9549375
[TBL] [Abstract][Full Text] [Related]
4. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
5. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
[TBL] [Abstract][Full Text] [Related]
6. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation.
Shirai H; Nakajima N; Higo J; Kidera A; Nakamura H
J Mol Biol; 1998 May; 278(2):481-96. PubMed ID: 9571065
[TBL] [Abstract][Full Text] [Related]
7. Predicting antibody complementarity determining region structures without classification.
Choi Y; Deane CM
Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
[TBL] [Abstract][Full Text] [Related]
8. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
[TBL] [Abstract][Full Text] [Related]
9. A new clustering of antibody CDR loop conformations.
North B; Lehmann A; Dunbrack RL
J Mol Biol; 2011 Feb; 406(2):228-56. PubMed ID: 21035459
[TBL] [Abstract][Full Text] [Related]
10. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
Tsuchiya Y; Mizuguchi K
Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
[TBL] [Abstract][Full Text] [Related]
11. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
[TBL] [Abstract][Full Text] [Related]
12. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
[TBL] [Abstract][Full Text] [Related]
13. Structural Classification of CDR-H3 in Single-Domain V
Kuroda D; Tsumoto K
Methods Mol Biol; 2023; 2552():61-79. PubMed ID: 36346585
[TBL] [Abstract][Full Text] [Related]
14. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
15. Antibody modeling assessment II. Structures and models.
Teplyakov A; Luo J; Obmolova G; Malia TJ; Sweet R; Stanfield RL; Kodangattil S; Almagro JC; Gilliland GL
Proteins; 2014 Aug; 82(8):1563-82. PubMed ID: 24633955
[TBL] [Abstract][Full Text] [Related]
16. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction.
Zhu K; Day T; Warshaviak D; Murrett C; Friesner R; Pearlman D
Proteins; 2014 Aug; 82(8):1646-55. PubMed ID: 24619874
[TBL] [Abstract][Full Text] [Related]
17. Prediction of hypervariable CDR-H3 loop structures in antibodies.
Reczko M; Martin AC; Bohr H; Suhai S
Protein Eng; 1995 Apr; 8(4):389-95. PubMed ID: 7567924
[TBL] [Abstract][Full Text] [Related]
18. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody.
Bates PA; Dokurno P; Freemont PS; Sternberg MJ
J Mol Biol; 1998 Dec; 284(3):549-55. PubMed ID: 9826497
[TBL] [Abstract][Full Text] [Related]
19. Analysis of 5518 unique, productively rearranged human VH3-23*01 gene sequences reveals CDR-H3 length-dependent usage of the IGHD2 gene family.
Chen L; Duan Y; Benatuil L; Stine WB
Protein Eng Des Sel; 2017 Sep; 30(9):603-609. PubMed ID: 28472386
[TBL] [Abstract][Full Text] [Related]
20. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
